GapMind for catabolism of small carbon sources

 

myo-inositol catabolism in Verminephrobacter eiseniae EF01-2

Best path

PS417_11885, PS417_11890, PS417_11895, iolG, iolE, iolD, iolB, iolC, iolJ, mmsA, tpi

Rules

Overview: Myo-inositol degradation in GapMind is based on MetaCyc pathways myo-inositol degradation I via inosose dehydratase (link) and pathway II inosose dehydrogenase (link).

29 steps (23 with candidates)

Or see definitions of steps

Step Description Best candidate 2nd candidate
PS417_11885 myo-inositol ABC transporter, substrate-binding component VEIS_RS00330 VEIS_RS00325
PS417_11890 myo-inositol ABC transporter, ATPase component VEIS_RS00315 VEIS_RS05355
PS417_11895 myo-inositol ABC transporter, permease component VEIS_RS00285 VEIS_RS10005
iolG myo-inositol 2-dehydrogenase VEIS_RS09040
iolE scyllo-inosose 2-dehydratase VEIS_RS00220 VEIS_RS00345
iolD 3D-(3,5/4)-trihydroxycyclohexane-1,2-dione hydrolase VEIS_RS00340
iolB 5-deoxy-D-glucuronate isomerase VEIS_RS00350
iolC 5-dehydro-2-deoxy-D-gluconate kinase VEIS_RS00335
iolJ 5-dehydro-2-deoxyphosphogluconate aldolase VEIS_RS00335 VEIS_RS22990
mmsA malonate-semialdehyde dehydrogenase VEIS_RS21480 VEIS_RS17125
tpi triose-phosphate isomerase VEIS_RS13720 VEIS_RS19750
Alternative steps:
eda 2-keto-3-deoxygluconate 6-phosphate aldolase VEIS_RS18275 VEIS_RS12520
HMIT myo-inositol:H+ symporter
iatA myo-inositol ABC transporter, ATPase component IatA VEIS_RS09915 VEIS_RS00315
iatP myo-inositol ABC transporter, permease component IatP VEIS_RS10005 VEIS_RS07195
ibpA myo-inositol ABC transporter, substrate-binding component IbpA VEIS_RS16590 VEIS_RS10000
iolF myo-inositol:H+ symporter
iolM 2-inosose 4-dehydrogenase VEIS_RS03770
iolN 2,4-diketo-inositol hydratase
iolO 5-dehydro-L-gluconate epimerase VEIS_RS15905
iolT myo-inositol:H+ symporter
kdgK 2-keto-3-deoxygluconate kinase VEIS_RS17245 VEIS_RS16575
PGA1_c07300 myo-inositol ABC transport, substrate-binding component VEIS_RS00310
PGA1_c07310 myo-inositol ABC transporter, permease component VEIS_RS00305 VEIS_RS00235
PGA1_c07320 myo-inositol ABC transporter, ATPase component VEIS_RS00300 VEIS_RS00240
SMIT1 myo-inositol:Na+ symporter
uxaE D-tagaturonate epimerase
uxuA D-mannonate dehydratase VEIS_RS17255 VEIS_RS18270
uxuB D-mannonate dehydrogenase VEIS_RS17250 VEIS_RS15405

Confidence: high confidence medium confidence low confidence
transporter – transporters and PTS systems are shaded because predicting their specificity is particularly challenging.

This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.

Links

Downloads

Related tools

About GapMind

Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.

A candidate for a step is "high confidence" if either:

where "other" refers to the best ublast hit to a sequence that is not annotated as performing this step (and is not "ignored").

Otherwise, a candidate is "medium confidence" if either:

Other blast hits with at least 50% coverage are "low confidence."

Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:

GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).

For more information, see:

If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know

by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory